CB Therapeutics (the “Company”), a frontrunner in biotechnology and precision fermentation, announces a monumental stride towards sustainability with the introduction of natural food and product colors, coupled with potent antioxidants. This innovative leap not only transforms coloration and nutrition but also sets a new benchmark for environmental responsibility in the food and industrial sectors.

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20240415387825/en/

(Photo: Business Wire)

Harnessing the transformative potential of precision fermentation, CB Therapeutics unveils a vibrant palette of natural colors, including striking orange from carrots (β-carotene), deep purple from beets (betalains), bold red from tomatoes (lycopene), sunny yellow from marigolds (lutein), and more. The synergy of these hues offers an extensive array of colors, catering to diverse consumer demands and industrial applications.

Beyond their aesthetic allure, these natural molecules serve as vital antioxidants and nutrients, fortifying cells against harmful free radicals and bolstering overall health. The adoption of CB Therapeutics' innovative solutions not only elevates product quality but also reinforces a commitment to consumer well-being and environmental stewardship, emphasized Sher Ali Butt, Co-Founder and CEO of CB Therapeutics.

Jacob Vogan, Co-Founder and CSO of CB Therapeutics, added that “in stark contrast to conventional methods, which often entail exorbitant costs, lengthy processes, and yield significant environmental repercussions, precision fermentation offers a sustainable and efficient alternative. By utilizing precision fermentation, CB Therapeutics significantly reduces carbon emissions, with estimates suggesting a reduction of metric tons of CO2 annually compared to traditional color production methods.”

CB Therapeutics is now looking to collaborate with partners in need of these sustainable colors. Interested companies should reach out to our CEO at sher@cbthera.com.

About CB Therapeutics

CB Therapeutics' expertise in synthetic genomics and bio-engineering has significantly advanced its proprietary production platform of microorganisms, enzymes, and production processes. After more than nine years of research and development, the CB Therapeutics team can produce a broad range of phytochemicals faster, utilizing fewer resources, at greater yields, and with more purity, consistency, and efficiency than competing platforms. CB Therapeutics operates from their new 16,000 sq. ft. facility in southern California.

Follow CB Therapeutics on Twitter: @CBTherapeutics

Follow CB Therapeutics on Instagram: @cb_thera

View source version on businesswire.com: https://www.businesswire.com/news/home/20240415387825/en/